[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Subcutaneous Drug Delivery Equipment Market Growth 2022-2028

January 2022 | 104 pages | ID: G4419E460181EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Subcutaneous Drug Delivery Equipment will have significant change from previous year. According to our (LP Information) latest study, the global Subcutaneous Drug Delivery Equipment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Subcutaneous Drug Delivery Equipment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Subcutaneous Drug Delivery Equipment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Subcutaneous Drug Delivery Equipment market, reaching US$ million by the year 2028. As for the Europe Subcutaneous Drug Delivery Equipment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Subcutaneous Drug Delivery Equipment players cover Boehringer Ingelheim, Eli Lily, Galaxo, and HMD pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Drug Delivery Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Syringe Based Subcutaneous Drug Delivery
  • Subcutaneous Implants
  • Pen Systems for Subcutaneous Drug Delivery
  • Auto Injectors
  • Pump Based Drug Delivery Systems
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • In-Patient
  • Out-Patient
  • Clinic
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Boehringer Ingelheim
  • Eli Lily
  • Galaxo
  • HMD pharmaceuticals
  • Merck
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Sanofi
  • Teva Pharmaceutical
  • Zogenix
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Country/Region, 2017, 2022 & 2028
2.2 Subcutaneous Drug Delivery Equipment Segment by Type
  2.2.1 Syringe Based Subcutaneous Drug Delivery
  2.2.2 Subcutaneous Implants
  2.2.3 Pen Systems for Subcutaneous Drug Delivery
  2.2.4 Auto Injectors
  2.2.5 Pump Based Drug Delivery Systems
2.3 Subcutaneous Drug Delivery Equipment Sales by Type
  2.3.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
  2.3.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2017-2022)
2.4 Subcutaneous Drug Delivery Equipment Segment by Application
  2.4.1 In-Patient
  2.4.2 Out-Patient
  2.4.3 Clinic
  2.4.4 Others
2.5 Subcutaneous Drug Delivery Equipment Sales by Application
  2.5.1 Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2017-2022)
  2.5.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2017-2022)

3 GLOBAL SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY COMPANY

3.1 Global Subcutaneous Drug Delivery Equipment Breakdown Data by Company
  3.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Company (2020-2022)
  3.1.2 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2020-2022)
3.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Company (2020-2022)
  3.2.1 Global Subcutaneous Drug Delivery Equipment Revenue by Company (2020-2022)
  3.2.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2020-2022)
3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Company
3.4 Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Subcutaneous Drug Delivery Equipment Product Location Distribution
  3.4.2 Players Subcutaneous Drug Delivery Equipment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION

4.1 World Historic Subcutaneous Drug Delivery Equipment Market Size by Geographic Region (2017-2022)
  4.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Geographic Region
4.2 World Historic Subcutaneous Drug Delivery Equipment Market Size by Country/Region (2017-2022)
  4.2.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Country/Region
4.3 Americas Subcutaneous Drug Delivery Equipment Sales Growth
4.4 APAC Subcutaneous Drug Delivery Equipment Sales Growth
4.5 Europe Subcutaneous Drug Delivery Equipment Sales Growth
4.6 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Growth

5 AMERICAS

5.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country
  5.1.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022)
  5.1.2 Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022)
5.2 Americas Subcutaneous Drug Delivery Equipment Sales by Type
5.3 Americas Subcutaneous Drug Delivery Equipment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region
  6.1.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region (2017-2022)
  6.1.2 APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2017-2022)
6.2 APAC Subcutaneous Drug Delivery Equipment Sales by Type
6.3 APAC Subcutaneous Drug Delivery Equipment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Subcutaneous Drug Delivery Equipment by Country
  7.1.1 Europe Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022)
  7.1.2 Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022)
7.2 Europe Subcutaneous Drug Delivery Equipment Sales by Type
7.3 Europe Subcutaneous Drug Delivery Equipment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Subcutaneous Drug Delivery Equipment by Country
  8.1.1 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022)
8.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type
8.3 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment
10.3 Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
10.4 Industry Chain Structure of Subcutaneous Drug Delivery Equipment

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Subcutaneous Drug Delivery Equipment Distributors
11.3 Subcutaneous Drug Delivery Equipment Customer

12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION

12.1 Global Subcutaneous Drug Delivery Equipment Market Size Forecast by Region
  12.1.1 Global Subcutaneous Drug Delivery Equipment Forecast by Region (2023-2028)
  12.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Drug Delivery Equipment Forecast by Type
12.7 Global Subcutaneous Drug Delivery Equipment Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Boehringer Ingelheim
  13.1.1 Boehringer Ingelheim Company Information
  13.1.2 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Product Offered
  13.1.3 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Boehringer Ingelheim Main Business Overview
  13.1.5 Boehringer Ingelheim Latest Developments
13.2 Eli Lily
  13.2.1 Eli Lily Company Information
  13.2.2 Eli Lily Subcutaneous Drug Delivery Equipment Product Offered
  13.2.3 Eli Lily Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Eli Lily Main Business Overview
  13.2.5 Eli Lily Latest Developments
13.3 Galaxo
  13.3.1 Galaxo Company Information
  13.3.2 Galaxo Subcutaneous Drug Delivery Equipment Product Offered
  13.3.3 Galaxo Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Galaxo Main Business Overview
  13.3.5 Galaxo Latest Developments
13.4 HMD pharmaceuticals
  13.4.1 HMD pharmaceuticals Company Information
  13.4.2 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Product Offered
  13.4.3 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 HMD pharmaceuticals Main Business Overview
  13.4.5 HMD pharmaceuticals Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Subcutaneous Drug Delivery Equipment Product Offered
  13.5.3 Merck Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments
13.6 Novartis
  13.6.1 Novartis Company Information
  13.6.2 Novartis Subcutaneous Drug Delivery Equipment Product Offered
  13.6.3 Novartis Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Novartis Main Business Overview
  13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
  13.7.1 Novo Nordisk Company Information
  13.7.2 Novo Nordisk Subcutaneous Drug Delivery Equipment Product Offered
  13.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Novo Nordisk Main Business Overview
  13.7.5 Novo Nordisk Latest Developments
13.8 Pfizer
  13.8.1 Pfizer Company Information
  13.8.2 Pfizer Subcutaneous Drug Delivery Equipment Product Offered
  13.8.3 Pfizer Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Pfizer Main Business Overview
  13.8.5 Pfizer Latest Developments
13.9 Sanofi
  13.9.1 Sanofi Company Information
  13.9.2 Sanofi Subcutaneous Drug Delivery Equipment Product Offered
  13.9.3 Sanofi Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Sanofi Main Business Overview
  13.9.5 Sanofi Latest Developments
13.10 Teva Pharmaceutical
  13.10.1 Teva Pharmaceutical Company Information
  13.10.2 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Product Offered
  13.10.3 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Teva Pharmaceutical Main Business Overview
  13.10.5 Teva Pharmaceutical Latest Developments
13.11 Zogenix
  13.11.1 Zogenix Company Information
  13.11.2 Zogenix Subcutaneous Drug Delivery Equipment Product Offered
  13.11.3 Zogenix Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Zogenix Main Business Overview
  13.11.5 Zogenix Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Syringe Based Subcutaneous Drug Delivery
Table 4. Major Players of Subcutaneous Implants
Table 5. Major Players of Pen Systems for Subcutaneous Drug Delivery
Table 6. Major Players of Auto Injectors
Table 7. Major Players of Pump Based Drug Delivery Systems
Table 8. Global Subcutaneous Drug Delivery Equipment Sales by Type (2017-2022) & (K Units)
Table 9. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
Table 10. Global Subcutaneous Drug Delivery Equipment Revenue by Type (2017-2022) & ($ million)
Table 11. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2017-2022)
Table 12. Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2017-2022) & (USD/Unit)
Table 13. Global Subcutaneous Drug Delivery Equipment Sales by Application (2017-2022) & (K Units)
Table 14. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Table 15. Global Subcutaneous Drug Delivery Equipment Revenue by Application (2017-2022)
Table 16. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2017-2022)
Table 17. Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2017-2022) & (USD/Unit)
Table 18. Global Subcutaneous Drug Delivery Equipment Sales by Company (2020-2022) & (K Units)
Table 19. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2020-2022)
Table 20. Global Subcutaneous Drug Delivery Equipment Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2020-2022)
Table 22. Global Subcutaneous Drug Delivery Equipment Sale Price by Company (2020-2022) & (USD/Unit)
Table 23. Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution and Sales Area
Table 24. Players Subcutaneous Drug Delivery Equipment Products Offered
Table 25. Subcutaneous Drug Delivery Equipment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Subcutaneous Drug Delivery Equipment Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Subcutaneous Drug Delivery Equipment Sales Market Share Geographic Region (2017-2022)
Table 30. Global Subcutaneous Drug Delivery Equipment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Subcutaneous Drug Delivery Equipment Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2017-2022)
Table 34. Global Subcutaneous Drug Delivery Equipment Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022) & (K Units)
Table 37. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2017-2022)
Table 38. Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2017-2022)
Table 40. Americas Subcutaneous Drug Delivery Equipment Sales by Type (2017-2022) & (K Units)
Table 41. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
Table 42. Americas Subcutaneous Drug Delivery Equipment Sales by Application (2017-2022) & (K Units)
Table 43. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Table 44. APAC Subcutaneous Drug Delivery Equipment Sales by Region (2017-2022) & (K Units)
Table 45. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2017-2022)
Table 46. APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2017-2022)
Table 48. APAC Subcutaneous Drug Delivery Equipment Sales by Type (2017-2022) & (K Units)
Table 49. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
Table 50. APAC Subcutaneous Drug Delivery Equipment Sales by Application (2017-2022) & (K Units)
Table 51. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Table 52. Europe Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022) & (K Units)
Table 53. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2017-2022)
Table 54. Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2017-2022)
Table 56. Europe Subcutaneous Drug Delivery Equipment Sales by Type (2017-2022) & (K Units)
Table 57. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
Table 58. Europe Subcutaneous Drug Delivery Equipment Sales by Application (2017-2022) & (K Units)
Table 59. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Subcutaneous Drug Delivery Equipment
Table 69. Key Market Challenges & Risks of Subcutaneous Drug Delivery Equipment
Table 70. Key Industry Trends of Subcutaneous Drug Delivery Equipment
Table 71. Subcutaneous Drug Delivery Equipment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Subcutaneous Drug Delivery Equipment Distributors List
Table 74. Subcutaneous Drug Delivery Equipment Customer List
Table 75. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Subcutaneous Drug Delivery Equipment Sales Market Forecast by Region
Table 77. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Subcutaneous Drug Delivery Equipment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Application (2023-2028)
Table 95. Boehringer Ingelheim Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 96. Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Product Offered
Table 97. Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 98. Boehringer Ingelheim Main Business
Table 99. Boehringer Ingelheim Latest Developments
Table 100. Eli Lily Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 101. Eli Lily Subcutaneous Drug Delivery Equipment Product Offered
Table 102. Eli Lily Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 103. Eli Lily Main Business
Table 104. Eli Lily Latest Developments
Table 105. Galaxo Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 106. Galaxo Subcutaneous Drug Delivery Equipment Product Offered
Table 107. Galaxo Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 108. Galaxo Main Business
Table 109. Galaxo Latest Developments
Table 110. HMD pharmaceuticals Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 111. HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Product Offered
Table 112. HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 113. HMD pharmaceuticals Main Business
Table 114. HMD pharmaceuticals Latest Developments
Table 115. Merck Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 116. Merck Subcutaneous Drug Delivery Equipment Product Offered
Table 117. Merck Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 118. Merck Main Business
Table 119. Merck Latest Developments
Table 120. Novartis Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 121. Novartis Subcutaneous Drug Delivery Equipment Product Offered
Table 122. Novartis Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 123. Novartis Main Business
Table 124. Novartis Latest Developments
Table 125. Novo Nordisk Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 126. Novo Nordisk Subcutaneous Drug Delivery Equipment Product Offered
Table 127. Novo Nordisk Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 128. Novo Nordisk Main Business
Table 129. Novo Nordisk Latest Developments
Table 130. Pfizer Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 131. Pfizer Subcutaneous Drug Delivery Equipment Product Offered
Table 132. Pfizer Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 133. Pfizer Main Business
Table 134. Pfizer Latest Developments
Table 135. Sanofi Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 136. Sanofi Subcutaneous Drug Delivery Equipment Product Offered
Table 137. Sanofi Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 138. Sanofi Main Business
Table 139. Sanofi Latest Developments
Table 140. Teva Pharmaceutical Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 141. Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Product Offered
Table 142. Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 143. Teva Pharmaceutical Main Business
Table 144. Teva Pharmaceutical Latest Developments
Table 145. Zogenix Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 146. Zogenix Subcutaneous Drug Delivery Equipment Product Offered
Table 147. Zogenix Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 148. Zogenix Main Business
Table 149. Zogenix Latest Developments

LIST OF FIGURES

Figure 1. Picture of Subcutaneous Drug Delivery Equipment
Figure 2. Subcutaneous Drug Delivery Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Drug Delivery Equipment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Subcutaneous Drug Delivery Equipment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Subcutaneous Drug Delivery Equipment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Syringe Based Subcutaneous Drug Delivery
Figure 10. Product Picture of Subcutaneous Implants
Figure 11. Product Picture of Pen Systems for Subcutaneous Drug Delivery
Figure 12. Product Picture of Auto Injectors
Figure 13. Product Picture of Pump Based Drug Delivery Systems
Figure 14. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type in 2021
Figure 15. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2017-2022)
Figure 16. Subcutaneous Drug Delivery Equipment Consumed in In-Patient
Figure 17. Global Subcutaneous Drug Delivery Equipment Market: In-Patient (2017-2022) & (K Units)
Figure 18. Subcutaneous Drug Delivery Equipment Consumed in Out-Patient
Figure 19. Global Subcutaneous Drug Delivery Equipment Market: Out-Patient (2017-2022) & (K Units)
Figure 20. Subcutaneous Drug Delivery Equipment Consumed in Clinic
Figure 21. Global Subcutaneous Drug Delivery Equipment Market: Clinic (2017-2022) & (K Units)
Figure 22. Subcutaneous Drug Delivery Equipment Consumed in Others
Figure 23. Global Subcutaneous Drug Delivery Equipment Market: Others (2017-2022) & (K Units)
Figure 24. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
Figure 25. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application in 2021
Figure 26. Subcutaneous Drug Delivery Equipment Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company in 2021
Figure 28. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region in 2021
Figure 30. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2017-2022)
Figure 31. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Country/Region in 2021
Figure 32. Americas Subcutaneous Drug Delivery Equipment Sales 2017-2022 (K Units)
Figure 33. Americas Subcutaneous Drug Delivery Equipment Revenue 2017-2022 ($ Millions)
Figure 34. APAC Subcutaneous Drug Delivery Equipment Sales 2017-2022 (K Units)
Figure 35. APAC Subcutaneous Drug Delivery Equipment Revenue 2017-2022 ($ Millions)
Figure 36. Europe Subcutaneous Drug Delivery Equipment Sales 2017-2022 (K Units)
Figure 37. Europe Subcutaneous Drug Delivery Equipment Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue 2017-2022 ($ Millions)
Figure 40. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2021
Figure 41. Americas Subcutaneous Drug Delivery Equipment Revenue Market Share by Country in 2021
Figure 42. United States Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region in 2021
Figure 47. APAC Subcutaneous Drug Delivery Equipment Revenue Market Share by Regions in 2021
Figure 48. China Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2021
Figure 55. Europe Subcutaneous Drug Delivery Equipment Revenue Market Share by Country in 2021
Figure 56. Germany Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Market Share by Country in 2021
Figure 63. Egypt Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Subcutaneous Drug Delivery Equipment Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment in 2021
Figure 69. Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
Figure 70. Industry Chain Structure of Subcutaneous Drug Delivery Equipment
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


More Publications